Stock Taper 
BDSX
$26.83
▼ DOWN 5.79% (-1.65)
KEY STATISTICS
Market Cap$218.40 M
52w High$31.31
52w Low$5.26
Dividend Yield—
Frequency—
P/E-8.46
Volume108.44K
Shares Out.8.14M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Scott Hutton
COMPENSATION 2026
Salary$643,404
Stock Awards$356,849
Incentive Plan Pay$710,280
All Other Comp.$3,500
Total$2,238,470
ABOUT
SECTOR
Healthcare
WENT PUBLIC
October 28, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
334
PRICE TARGET
Target High$35.00
Target Low$26.00
Target Median$32.00
Target Consensus$31.00
UPCOMING EARNINGS
DateNov 2, 2026
DayMonday
Rev. Est.$27.55M
NOV
2
MON
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-09-15 | Reverse | 1:20 |
PRICE
$26.83 ▼ DOWN 5.79% (−$1.65)About Biodesix, Inc.
https://www.biodesix.com ↗Biodesix, Inc. provides data-driven blood-based diagnostic tests for lung cancer risk assessment, mutation detection, and COVID-19, supporting clinical decision-making and biopharmaceutical research.
INDUSTRY
Medical - Diagnostics & Research
A PRODUCT BIODESIX, INC. IS KNOWN FOR
Nodify XL2
The Nodify XL2 is a blood-based proteomic test that helps clinicians identify likely benign lung nodules, supporting decision-making to reduce unnecessary invasive procedures for patients at low-to-moderate lung cancer risk.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Diagnostic Tests | $19.84M | $25.15M ▲ | $22.29M ▼ | $25.35M ▲ |
 | Development Services | $1.93M | $3.61M ▲ | $3.26M ▼ | $1.51M ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
11
LISTED HERE
2
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
47.27%
HOLDERS
61
TOP 12 OF 61 · RANKED BY POSITION SIZE
Aigh Capital Management LLC
Telemark Asset Management, LLC
Abrdn Plc
Soleus Capital Management, L.P.
Blackrock Inc.
Birchview Capital, LP
Opaleye Management Inc.
Cannell & Co.
Vanguard Group Inc
Marshall Wace, Llp
Essex Investment Management Co LLC
Monashee Investment Management LLC
RATINGS SNAPSHOT
Overall rating: D+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
10 PERCENT OWNER, OTHER: EMERITUS DIRECTOR
SCHULER JACK W
Purchase · 15.0K shares
2026-08-12
★
10 PERCENT OWNER, OTHER: EMERITUS DIRECTOR
SCHULER JACK W
Purchase · 13.7K shares
2026-08-11
★
10 PERCENT OWNER, OTHER: EMERITUS DIRECTOR
SCHULER JACK W
Purchase · 13.9K shares
2026-08-10
★
DIRECTOR, OTHER: CHAIRMAN
PATIENCE JOHN
Purchase · 1.4K shares
2026-06-30
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 OKUR | $3.79 | COMPARE |
 INMB | $2.33 | COMPARE |
 XLO | $9.00 | COMPARE |
 ALGS | $6.91 | COMPARE |
 PDSB | $0.21 | COMPARE |
 SKYE | $1.77 | COMPARE |